Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.22 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.22 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.22 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.22 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.128ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.128ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.128ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.128NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.405ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.405ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.405NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.296ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.296ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.296ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.296NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.412ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.412ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.412ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.412NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.421ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.421ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.421ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.421NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.364ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.364ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.364ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.364NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.82ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.82ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.82NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used